Paper25753670
Short antisense-locked nucleic acids (all-LNAs) correct alternative splicing abnormalities in myotonic dystrophy.
Wojtkowiak-Szlachcic A and 7 others. Nucleic Acids Res, 2015. Cited by 75 papers, by iCite.
Cite this record
ConductScience Library. Short antisense-locked nucleic acids (all-LNAs) correct alternative splicing abnormalities in myotonic dystrophy. Papers, record 25753670. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25753670
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alternative Splicing | Major topic |
| Myotonic Dystrophy | Major topic |
| Oligonucleotides | Major topic |
| Oligonucleotides, Antisense | Major topic |
| 3' Untranslated Regions | |
| Animals | |
| Base Sequence | |
| Cell Line | |
| Disease Models, Animal | |
| HEK293 Cells | |
| HeLa Cells | |
| Humans | |
| Mice | |
| Mice, Transgenic | |
| Mutant Proteins | |
| Myotonin-Protein Kinase | |
| RNA-Binding Proteins | |
| Trinucleotide Repeat Expansion |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| U54 NS048843 | NINDS NIH HHS | United States | U54NS048843 | PubMed and NIH |
| NS048843 | NINDS NIH HHS | United States | U54NS048843 | PubMed and NIH |
Source NIH RePORTER
References55
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11528389 | Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. | Nat Genet | 2001 | https://conductscience.org/library/papers/11528389 | PubMed |
| 2 | 10970838 | Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy. | EMBO J | 2000 | https://conductscience.org/library/papers/10970838 | PubMed |
| 3 | 23183533 | RNA interference targeting CUG repeats in a mouse model of myotonic dystrophy. | Mol Ther | 2013 | https://conductscience.org/library/papers/23183533 | PubMed |
| 4 | 22901804 | Transcriptome-wide regulation of pre-mRNA splicing and mRNA localization by muscleblind proteins. | Cell | 2012 | https://conductscience.org/library/papers/22901804 | PubMed |
| 5 | 9207101 | Expansion of a CUG trinucleotide repeat in the 3' untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts. | Proc Natl Acad Sci U S A | 1997 | https://conductscience.org/library/papers/9207101 | PubMed |
| 6 | 10976074 | Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. | Science | 2000 | https://conductscience.org/library/papers/10976074 | PubMed |
| 7 | 24824895 | Small molecule kinase inhibitors alleviate different molecular features of myotonic dystrophy type 1. | RNA Biol | 2014 | https://conductscience.org/library/papers/24824895 | PubMed |
| 8 | 23929620 | Splicing biomarkers of disease severity in myotonic dystrophy. | Ann Neurol | 2013 | https://conductscience.org/library/papers/23929620 | PubMed |
| 9 | 10805816 | Potent and nontoxic antisense oligonucleotides containing locked nucleic acids. | Proc Natl Acad Sci U S A | 2000 | https://conductscience.org/library/papers/10805816 | PubMed |
| 10 | 23308382 | Systemic delivery of a Peptide-linked morpholino oligonucleotide neutralizes mutant RNA toxicity in a mouse model of myotonic dystrophy. | Nucleic Acid Ther | 2013 | https://conductscience.org/library/papers/23308382 | PubMed |
| 11 | 1310900 | Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. | Cell | 1992 | https://conductscience.org/library/papers/1310900 | PubMed |
| 12 | 18008009 | Correction of ClC-1 splicing eliminates chloride channelopathy and myotonia in mouse models of myotonic dystrophy. | J Clin Invest | 2007 | https://conductscience.org/library/papers/18008009 | PubMed |
| 13 | 8358430 | Effect of the myotonic dystrophy (DM) mutation on mRNA levels of the DM gene. | Nat Genet | 1993 | https://conductscience.org/library/papers/8358430 | PubMed |
| 14 | 19854938 | Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagents. | Nucleic Acids Res | 2010 | https://conductscience.org/library/papers/19854938 | PubMed |
| 15 | 22802532 | Ptbp2 represses adult-specific splicing to regulate the generation of neuronal precursors in the embryonic brain. | Genes Dev | 2012 | https://conductscience.org/library/papers/22802532 | PubMed |
| 16 | 23806903 | Induction and reversal of myotonic dystrophy type 1 pre-mRNA splicing defects by small molecules. | Nat Commun | 2013 | https://conductscience.org/library/papers/23806903 | PubMed |
| 17 | 16717059 | Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy. | Hum Mol Genet | 2006 | https://conductscience.org/library/papers/16717059 | PubMed |
| 18 | 21345934 | Mechanisms of single-stranded phosphorothioate modified antisense oligonucleotide accumulation in hepatocytes. | Nucleic Acids Res | 2011 | https://conductscience.org/library/papers/21345934 | PubMed |
| 19 | 19608921 | Reversal of RNA dominance by displacement of protein sequestered on triplet repeat RNA. | Science | 2009 | https://conductscience.org/library/papers/19608921 | PubMed |
| 20 | 22284355 | RNA-based therapeutics: current progress and future prospects. | Chem Biol | 2012 | https://conductscience.org/library/papers/22284355 | PubMed |
Cited by59
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 75 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42339623 | Bottlebrush polymer conjugates for enhanced antisense oligonucleotide therapy in myotonic dystrophy type 1. | Nucleic Acids Res | 2026 | https://conductscience.org/library/papers/42339623 | PubMed |
| 41797662 | Targeting Expanded CUG and CTG Repeats as a Therapeutic Approach for Myotonic Dystrophy Type 1 (DM1). | ChemMedChem | 2026 | https://conductscience.org/library/papers/41797662 | PubMed |
| 41512040 | A pothole-filling strategy for selective targeting of rCUG-repeats associated with myotonic dystrophy type 1. | Proc Natl Acad Sci U S A | 2026 | https://conductscience.org/library/papers/41512040 | PubMed |
| 41018201 | Therapeutic advances in type 1 myotonic dystrophy complicated with type 2 diabetes mellitus. | Front Neurol | 2025 | https://conductscience.org/library/papers/41018201 | PubMed |
| 40829807 | Promoter-targeted small RNA duplexes increase MBNL1 transcription and mitigate myotonic dystrophy-associated spliceopathy. | Nucleic Acids Res | 2025 | https://conductscience.org/library/papers/40829807 | PubMed |
| 40808372 | Changes in RNA splicing as a surrogate endpoint for myotonic dystrophy Type 1 (DM1) clinical trials. | J Neuromuscul Dis | 2026 | https://conductscience.org/library/papers/40808372 | PubMed |
| 40720012 | Tips to Design Effective Splice-Switching Antisense Oligonucleotides for Exon Skipping and Exon Inclusion. | Methods Mol Biol | 2025 | https://conductscience.org/library/papers/40720012 | PubMed |
| 40603638 | Molecular genetics of myotonic dystrophy and the evolution of therapeutic approaches. | J Hum Genet | 2025 | https://conductscience.org/library/papers/40603638 | PubMed |
| 39711475 | Experimental and computational investigations of RNA duplexes containing N7-regioisomers of adenosine and LNA-adenosine. | Nucleic Acids Res | 2025 | https://conductscience.org/library/papers/39711475 | PubMed |
| 39501809 | Dominantly inherited muscle disorders: understanding their complexity and exploring therapeutic approaches. | Dis Model Mech | 2024 | https://conductscience.org/library/papers/39501809 | PubMed |
| 37882878 | Modulatory role of RNA helicases in MBNL-dependent alternative splicing regulation. | Cell Mol Life Sci | 2023 | https://conductscience.org/library/papers/37882878 | PubMed |
| 37397246 | Promising AAV.U7snRNAs vectors targeting DMPK improve DM1 hallmarks in patient-derived cell lines. | Front Cell Dev Biol | 2023 | https://conductscience.org/library/papers/37397246 | PubMed |
| 37200862 | Block or degrade? Balancing on- and off-target effects of antisense strategies against transcripts with expanded triplet repeats in DM1. | Mol Ther Nucleic Acids | 2023 | https://conductscience.org/library/papers/37200862 | PubMed |
| 37059588 | Long non-coding RNA HOXA11-AS regulates ischemic neuronal death by targeting miR-337-3p/YBX1 signaling pathway: protective effect of dexmedetomidine. | Aging (Albany NY) | 2023 | https://conductscience.org/library/papers/37059588 | PubMed |
| 36769018 | Application of Antisense Conjugates for the Treatment of Myotonic Dystrophy Type 1. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36769018 | PubMed |
| 36420218 | Sustainable recovery of MBNL activity in autoregulatory feedback loop in myotonic dystrophy. | Mol Ther Nucleic Acids | 2022 | https://conductscience.org/library/papers/36420218 | PubMed |
| 36401033 | Peptide-Conjugated PMOs for the Treatment of Myotonic Dystrophy. | Methods Mol Biol | 2023 | https://conductscience.org/library/papers/36401033 | PubMed |
| 36399603 | Study of an RNA-Focused DNA-Encoded Library Informs Design of a Degrader of a r(CUG) Repeat Expansion. | J Am Chem Soc | 2022 | https://conductscience.org/library/papers/36399603 | PubMed |
| 36362145 | Recent Progress and Challenges in the Development of Antisense Therapies for Myotonic Dystrophy Type 1. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36362145 | PubMed |
| 35563013 | Molecular Therapies for Myotonic Dystrophy Type 1: From Small Drugs to Gene Editing. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35563013 | PubMed |
Genes30
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/25753670
GET https://conductscience.org/api/papers/v1/25753670/references?page=2